Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank33
3Y CAGR-3.4%
5Y CAGR-1.5%
Year-over-Year Change
Quality of reported income
3Y CAGR
-3.4%/yr
Annual compound
5Y CAGR
-1.5%/yr
Consistent
Percentile
P33
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.89 | +241.2% |
| 2024 | -0.63 | +97.0% |
| 2023 | -20.91 | -2209.8% |
| 2022 | 0.99 | -0.3% |
| 2021 | 0.99 | +3.1% |
| 2020 | 0.96 | -54.5% |
| 2019 | 2.12 | - |